STJ  St. Jude Medical Inc.

Exchange

NYSE

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.

14.67B

Vuru Grade

68.96/100

Current Price

$51.21
-1.84 (-3.47%)

Growth Price

$53.24
Fairly valued

Stability Price

$20.22
Overvalued by 60.52%

Company Metrics

  • P/E 16.68
  • P/S 2.74
  • P/B 3.76
  • EPS 3.07
  • Cash ROIC 14.54%
  • Cash Ratio 0.54
  • Dividend 1.16 / 2.2%
  • Avg. Vol. 1.97M
  • Shares 286.47M
  • Market Cap. 14.67B

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Investors Tracking St. Jude Medical, Inc. (NYSE:STJ)'s
Vanguard Tribune - 6 hours ago
Investors are following St. Jude Medical, Inc. (NYSE:STJ)'s stock movement, which recorded the first trade at 52.33 and was hovering around 51.21 lately.
St. Jude Medical Inc. (STJ) Falls 3.58% for February 05
Equities.com - Feb 5, 2016
One of the S&P 500's big losers for Friday February 05 was St. Jude Medical Inc. (STJ). The company's stock fell 3.58% to $51.15 on volume of 1.94 million shares.
Decatur Capital Management Inc. Has $12747000 Stake in St. Jude Medical, Inc ... - Financial Market News
ST Jude Medical Inc (NYSE:STJ) Q3 2015 Sentiment Change - WallStreet.org
St Jude Medical is Oversold
Forbes - Feb 3, 2016
But making St Jude Medical Inc an even more interesting and timely stock to look at, is the fact that in trading on Wednesday, shares of STJ entered into oversold territory, changing hands as low as $52.045 per share.
Top Stocks of the day: St. Jude Medical Inc. (NYSE:STJ)
The News Journal - Feb 5, 2016
Amid the topmost stocks in today's market is St. Jude Medical Inc. (NYSE:STJ). St. Jude Medical Inc. had a market cap of 14867.92, indicating that it has a good hold on the market value of the shares outstanding. The current market cap of St. Jude ...
Bremer Trust National Association Sells 2148 Shares of St. Jude Medical, Inc ... - Financial Market News
St. Jude Medical, Inc. (STJ) Stake Increased by AT Bancorp - Intercooler Financial
Jefferies Group Reiterates "Hold" Rating for St. Jude Medical, Inc. (STJ)
EMQ - Feb 1, 2016
St. Jude Medical logo St. Jude Medical, Inc. (NYSE:STJ)'s stock had its “hold” rating restated by analysts at Jefferies Group in a research report issued to clients and investors on Thursday, MarketBeat.
St. Jude Medical, Inc. (STJ) Assigned "A" Credit Rating - IRA Market Report
Oppenheimer Weighs in on St. Jude Medical, Inc.'s Q1 2016 Earnings (STJ) - Corvus Business Newswire
St. Jude Medical, Inc. (STJ) Rating Reiterated by Canaccord Genuity
EMQ - Jan 17, 2016
St. Jude Medical logo St. Jude Medical, Inc. (NYSE:STJ)'s stock had its “sell” rating restated by research analysts at Canaccord Genuity in a research report issued on Sunday, AnalystRatingsNetwork.
Form 8-K ST JUDE MEDICAL INC For: Jan 13 - StreetInsider.com
St. Jude Medical Inc (NYSE:STJ) Had Its Price Objective Lowered by 1.54 % at ... - OctaFinance.com
St. Jude Medical, Inc. (STJ) Announces Earnings Results
EMQ - Jan 29, 2016
St. Jude Medical logo St. Jude Medical, Inc. (NYSE:STJ) posted its earnings results on Wednesday. The medical technology company reported $1.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.01 by $0.01, Analyst ...
St. Jude Medical, Inc. (STJ) Given Buy Rating at Needham & Company LLC - IRA Market Report
St. Jude Medical, Inc. 16.9% Potential Upside Now Implied by Oppenheimer - DirectorsTalk Interviews
St. Jude Medical Announces FDA Approval of the Proclaim Elite SCS System, a ...
Business Wire (press release) - Nov 19, 2015
BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company and an international leader in chronic pain therapy development, today announced FDA approval of the new Proclaim™ Elite Spinal Cord Stimulation System, the first ...
St. Jude Medical Gets FDA Approval For Proclaim Elite SCS System - Nasdaq
St. Jude Medical lowers earnings outlook
Minneapolis Star Tribune - Oct 21, 2015
St. Jude Medical Inc. shares closed down more than 8 percent Wednesday as the medical device manufacturer trimmed its financial outlook on disappointing news about two key heart devices.
Why St. Jude Medical (STJ) Stock Is Down Today - TheStreet.com
St. Jude Medical Q3 Earnings Meet, Currency Woes Prevail - Zacks.com
FDA Classifies St. Jude Medical Field Action for 447 of the Company's Optisure ...
Business Wire (press release) - Jan 22, 2016
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that a previously communicated voluntary global field safety action related to the company's Optisure™ Dual Coil Defibrillation ...
St. Jude Medical (STJ) Says Optisure Dual Coil Defibrillation Leads Now ... - StreetInsider.com